Use of Levosimendan in Patients with Advanced Heart Failure: An Update

Levosimendan is an inodilator drug that, given its unique pharmacological actions and safety profile, represents a viable therapeutic option in patients with heart failure with reduced ejection fraction in the advanced stage of the disease (advHFrEF). Pulsed levosimendan infusion in patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarone, Daniele, Kittleson, Michelle M., Pollesello, Piero, Marini, Marco, Iacoviello, Massimo, Oliva, Fabrizio, Caiazzo, Angelo, Petraio, Andrea, Pacileo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659135/
https://www.ncbi.nlm.nih.gov/pubmed/36362634
http://dx.doi.org/10.3390/jcm11216408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659135/
https://www.ncbi.nlm.nih.gov/pubmed/36362634
http://dx.doi.org/10.3390/jcm11216408

Ejemplares similares